BSE NSE
Your Result on : Company News Details
Shukra Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524632
ISIN Demat
INE551C01044
Book Value (Rs)
1.2397304
NSE Symbol
N.A
Divident Yield %
0.19
Market Cap
(Rs In Cr.)
569
P/E (TTM)
68.42
EPS (TTM)
0.19
Face Value
(Rs)
1
Back
Shukra Pharmaceuticals Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 14Th February 2025 And Submission Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2024.
14-Feb-25   Hrs IST

Outcome of Board Meeting held today i.e. on 14th February 2025 and 1. submission of Un-audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2024. 2. Appointment Mr. Jay Gandhi as Internal Auditor for FY 2024-25 The brief information as required under Regulation 30 of SEBI (LODR) regulations 2015 for the said matter is attached as Annexure A. 3. Appointment of Ms. Shilpa Shah (Practising Company Secretary) as Secretarial Auditor for FY 2024-25 The brief information as required under Regulation 30 of SEBI (LODR) regulations 2015 for the said matter is attached as Annexure B.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)